Cargando…
Infliximab treatment–induced paradoxical psoriasiform reaction in patient with psoriasis vulgaris showing positive lymphocyte transportation test reaction
Autores principales: | Ishii-Osai, Yasue, Yoneta, Akihiro, Mizugaki, Noriko, Takahashi, Hitomi, Yamashita, Toshiharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808732/ https://www.ncbi.nlm.nih.gov/pubmed/27051738 http://dx.doi.org/10.1016/j.jdcr.2015.05.007 |
Ejemplares similares
-
Psoriasiform Eruption Secondary to PI3K-delta Inhibitor: Expanding the Spectrum of Psoriasiform Paradoxical Reactions?
por: PESQUÉ, David, et al.
Publicado: (2021) -
Psoriasis paradox—infliximab-induced psoriasis in a patient with Crohn’s disease: a case report and mini-review
por: Mohammed, Reem Hamdy A, et al.
Publicado: (2023) -
Infliximab-Associated Psoriasiform Dermatitis: Case Report and Review of a Seemingly Paradoxical Inflammatory Response
por: Loh, Tiffany Y, et al.
Publicado: (2016) -
Arthropathic psoriasis complicated by a paradoxical reaction in the form of erythrodermic psoriasis following adalimumab and by an allergic reaction following infliximab which was successfully managed with secukinumab
por: Tichy, Martin
Publicado: (2019) -
Use of Infliximab to Treat Paradoxical Tuberculous Meningitis Reactions
por: Marais, Ben J, et al.
Publicado: (2020)